Laura Soucek, PhD

Institució Catalana de Recerca i Estudis Avançats (ICREA), Vall d'Hebron Institute of Oncology (VHIO), Peptomyc, S.L. Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Spain

Poster(s):

• (P 408) OSTEOMYC: A PHASE 2 PILOT STUDY TO EVALIATE THE SAFETY AND THE ANTITUMOR ACTIVITY OF THE MYC INHIBITOR OMO-103 ADMINISTERED INTRAVENOUSLY IN PATIENTS WITH ADVANCED HIGH GRADE OSTEOSARCOMA